Fig. 2From: Salvianolic acid a inhibits platelet activation and aggregation in patients with type 2 diabetes mellitusEffects of Salvianolic acid A (SAA) on platelet aggregation. Platelet-rich plasma (PRP) was preincubated for 10 min with SAA (0.1 mg/ml) or a vehicle. Platelet aggregation was initiated with ADP (4 μM) or thrombin (0.4 U/ml)Back to article page